Chorionic Gonadotrophin, Human
Note: These products are not licensed in Australia at the time of publication. The information in this monograph applies to these specific brands, formulations and strengths only.
Trade name
Brevactid, Choriomon, Pregnyl
Presentation and preparation
|
Vial size
(powder volume) |
Fluid to add
|
Volume to add
|
Resulting concentration
|
|---|---|---|---|
| 1500 units (negligible) |
Diluent provided | Full contents provided (1 mL) | 1500 units/mL |
| 5000 mg (negligible) |
Diluent provided | Full contents provided (1 mL) | 5000 units/mL |
Reconstitute with full contents of diluent provided. Roll vial gently, do not shake. Use solution immediately after reconstitution.
IV administration
Never administer intravenously.
Other routes of administration
IM: Suitable. Give reconstituted solution undiluted.
SC: Suitable: Choriomon only. Give reconstituted solution undiluted.
Additional information
Observe closely for anaphylactic reactions.
Potentially hazardous medication: may require special handling precautions; refer to RCH Safe handling of Hazardous Medicines Procedure or relevant local guideline.
Use immediately after reconstitution. Discard any unused vial contents.
Protect from light during storage.